文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关间质性肺病的识别、监测与管理

Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
PubMed 文献 · Arthritis Rheumatol · 2023-10-04

间质性肺病(ILD)是类风湿关节炎(RA)的常见并发症,与死亡率显著增加相关。部分RA-ILD危险因素已被识别,但无危险因素者仍可发生ILD,需筛查工具助早期发现,密切监测进展以及时治疗;抗纤维化治疗在包括RA-ILD的进展性纤维化ILD中可减缓肺功能下降,管理应基于多学科评估ILD严重度、进展及关节疾病活动度,风湿科与呼吸科紧密协作至关重要。

要点

  • ILD是RA常见并发症,与死亡率显著增加相关。
  • 已识别多种RA-ILD危险因素,但无危险因素者仍可发生ILD。
  • RA-ILD管理应基于多学科评估ILD严重度、进展及关节疾病活动度。

核心结论

  • RA-ILD的识别、监测与管理需筛查工具助早期发现、密切监测进展以及时治疗,管理应基于多学科评估ILD严重度、进展及关节疾病活动度,风湿科与呼吸科紧密协作至关重要。

研究设计与样本

  • 原文为综述,未报告具体检索范围。

主要发现

  • ILD是RA的常见并发症,与死亡率显著增加相关。
  • 已识别多种RA-ILD危险因素,但无危险因素者仍可发生ILD。
  • 抗纤维化治疗在包括RA-ILD的进展性纤维化ILD临床试验中可减缓肺功能下降。
  • 免疫调节治疗在减缓RA-ILD进展方面的疗效仍存争议。

临床怎么用

  • RA-ILD管理应基于多学科评估ILD严重度、进展及关节疾病活动度。
  • 风湿科与呼吸科紧密协作对优化患者照护至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Interstitial lung disease (ILD) is a frequent complication of rheumatoid arthritis (RA) that is associated with a significant increase in mortality. Several risk factors for the development of ILD in patients with RA have been identified, but ILD can still develop in the absence of these risk factors. Screening tools for RA-ILD are required to facilitate early detection of RA-ILD. Close monitoring of patients with RA-ILD for progression is crucial to enable timely implementation of treatment strategies to improve outcomes. Patients with RA are commonly treated with immunomodulatory therapies, although their efficacy in slowing the progression of RA-ILD remains the subject of debate. Clinical trials have shown that antifibrotic therapies slow decline in lung function in patients with progressive fibrosing ILDs, including patients with RA-ILD. The management of patients with RA-ILD should be based on multidisciplinary evaluation of the severity and progression of their ILD and the activity of their articular disease. Close collaboration between rheumatologists and pulmonologists is essential to optimize patient care.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Koduri G, Solomon JJ. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023. PMID: 37395725. doi:10.1002/art.42640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。